Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Thrombosis Research

Volumn 128, Issue 2, 2011, Pages 169-173

  Yamaguchi, Yusuke ^a   Moriki, Takanori ^a   Igari, Atsuko ^a   Nakagawa, Terumichi ^a   Wada, Hideo ^b   Matsumoto, Masanori ^c   Fujimura, Yoshihiro ^c   Murata, Mitsuru ^a  

^a KEIO UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13; Autoantibody; Phage surface display system; Thrombotic thrombocytopenic purpura; Von Willebrand factor

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; PROTEIN G; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY TITER; ARTICLE; BINDING SITE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCREENING; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BINDING SITES, ANTIBODY; EPITOPE MAPPING; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC; YOUNG ADULT;

EID: 79960425069     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.03.010     Document Type: Article

References (34)

1. J.L. Moake, C.K. Rudy, J.H. Troll, M.J. Weinstein, N.M. Colannino, and J. Azocar Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N Engl J Med 307 1982 1432 1435 (Pubitemid 13234018)
2. M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P.A. Kyrle, and B. Brenner von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1998 1578 1584 (Pubitemid 28536132)
3. H.M. Tsai, and E.C. Lian Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N Engl J Med 339 1998 1585 1594 (Pubitemid 28536133)
4. J.F. Dong, J.L. Moake, L. Nolasco, A. Bernardo, W. Arceneaux, and C.N. Shrimpton ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions Blood 100 2002 4033 4039 (Pubitemid 35396870)
5. K. Fujikawa, H. Suzuki, B. McMullen, and D. Chung Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family Blood 98 2001 1662 1666
6. H.E. Gerritsen, R. Robles, B. Lammle, and M. Furlan Partial amino acid sequence of purified von Willebrand factor-cleaving protease Blood 98 2001 1654 1661
7. K. Soejima, N. Mimura, M. Hirashima, H. Maeda, T. Hamamoto, and T. Nakagaki A novel human metalloprotease synthesized in the liver and secreted into the Blood: possibly, the von Willebrand factor-cleaving protease? J Biochem 130 2001 475 480 (Pubitemid 33021590)
8. X. Zheng, D. Chung, T.K. Takayama, E.M. Majerus, J.E. Sadler, and K. Fujikawa Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura J Biol Chem 276 2001 41059 41063
9. K. Soejima, M. Matsumoto, K. Kokame, H. Yagi, H. Ishizashi, and H. Maeda ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage Blood 102 2003 3232 3237 (Pubitemid 37314760)
10. X. Zheng, K. Nishio, E.M. Majerus, and J.E. Sadler Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13 J Biol Chem 278 2003 30136 30141 (Pubitemid 36962406)
11. J. Ai, P. Smith, S. Wang, P. Zhang, and X.L. Zheng The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor J Biol Chem 280 2005 29428 29434 (Pubitemid 41177015)
12. E.M. Majerus, P.J. Anderson, and J.E. Sadler Binding of ADAMTS13 to von Willebrand factor J Biol Chem 280 2005 21773 21778 (Pubitemid 40827825)
13. Z. Tao, Y. Peng, L. Nolasco, S. Cal, C. Lopez-Otin, and R. Li Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions Blood 106 2005 4139 4145 (Pubitemid 41775919)
14. P. Zhang, W. Pan, A.H. Rux, B.S. Sachais, and X.L. Zheng The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow Blood 110 2007 1887 1894 (Pubitemid 47443901)
15. F. Scheiflinger, P. Knobl, B. Trattner, B. Plaimauer, G. Mohr, and M. Dockal Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura Blood 102 2003 3241 3243 (Pubitemid 37314762)
16. S.G. Shelat, P. Smith, J. Ai, and X.L. Zheng Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo J Thromb Haemost 4 2006 1707 1717 (Pubitemid 44144797)
17. S. Ferrari, F. Scheiflinger, M. Rieger, G. Mudde, M. Wolf, and P. Coppo Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity Blood 109 2007 2815 2822 (Pubitemid 46482076)
18. S. Ferrari, G.C. Mudde, M. Rieger, A. Veyradier, J.A. Hovinga, and F. Scheiflinger IgG-subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura J Thromb Haemost 7 2009 1703 1710
19. X.L. Zheng, R.M. Kaufman, L.T. Goodnough, and J.E. Sadler Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura Blood 103 2004 4043 4049 (Pubitemid 38685342)
20. P. Coppo, M. Wolf, A. Veyradier, A. Bussel, S. Malot, and G.A. Millot Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura Br J Haematol 132 2006 66 74 (Pubitemid 43381572)
21. J.A. Hovinga, S.K. Vesely, D.R. Terrell, B. Lammle, and J.N. George Survival and relapse in patients with thrombotic thrombocytopenic purpura Blood 115 2010 1500 1511 quiz 1662
22. M. Rieger, P.M. Mannucci, J.A. Hovinga, A. Herzog, G. Gerstenbauer, and C. Konetschny ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases Blood 106 2005 1262 1267 (Pubitemid 41129589)
23. C. Klaus, B. Plaimauer, J.D. Studt, F. Dorner, B. Lammle, and P.M. Mannucci Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura Blood 103 2004 4514 4519 (Pubitemid 38745978)
24. B.M. Luken, E.A. Turenhout, J.J. Hulstein, J.A. Mourik, R. Fijnheer, and J. Voorberg The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura Thromb Haemost 93 2005 267 274 (Pubitemid 40253731)
25. W. Zhou, L. Dong, D. Ginsburg, E.E. Bouhassira, and H.M. Tsai Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy? J Biol Chem 280 2005 39934 39941 (Pubitemid 41779128)
26. B.M. Luken, P.H. Kaijen, E.A. Turenhout, J.A. Hovinga, J.A. Mourik, and R. Fijnheer Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura J Thromb Haemost 4 2006 2355 2364 (Pubitemid 44575429)
27. B.M. Luken, E.A. Turenhout, P.H. Kaijen, M.J. Greuter, W. Pos, and J.A. Mourik Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP Thromb Haemost 96 2006 295 301 (Pubitemid 44377812)
28. X.L. Zheng, H.M. Wu, D. Shang, E. Falls, C.G. Skipwith, and S.R. Cataland Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura Haematologica 95 2010 1555 1561
29. T. Moriki, I.N. Maruyama, A. Igari, Y. Ikeda, and M. Murata Identification of ADAMTS13 peptide sequences binding to von Willebrand factor Biochem Biophys Res Commun 391 2010 783 788
30. K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 29 2005 93 100 (Pubitemid 40524057)
31. S. Kato, M. Matsumoto, T. Matsuyama, A. Isonishi, H. Hiura, and Y. Fujimura Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity Transfusion 46 2006 1444 1452 (Pubitemid 44117975)
32. W. Pos, J.T. Crawley, R. Fijnheer, J. Voorberg, D.A. Lane, and B.M. Luken An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF Blood 115 2010 1640 1649
33. M. Akiyama, S. Takeda, K. Kokame, J. Takagi, and T. Miyata Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor Proc Natl Acad Sci USA 106 2009 19274 19279
34. S.Y. Jin, C.G. Skipwith, and X.L. Zheng Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor Blood 115 2010 2300 2310